Singapore Research Board develops anti-cancer compound expected to see results within two years
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
theof the Institute of Molecular and Cell Biology (
IMCB), part of theof the Singapore Science and Technology Research Council (
A-STAR), has signed an agreement with private biotech organization S.Bio
to develop aof anti-cancer compounds,hopes to find at least one compound that can be effective against cancer within two yearsis confident that it will be able to achievewithin two years,they will be working with the new Pilot Treatment Center under the New Science and Technology Research Agency toconvert these identified anti-cancer potential compounds into clinically available drugs, " said Eander Carrison, president of s.BioFounded in the second OOO year of the Company is the Economic Development Bureau and the United States pharmaceutical factory Qilong co-establishment of research and developmentdivisionIn the past, it has made good progress in cancer research, including identifying a compound called H-dac enzyme in patients withblood cancer that is effective against lung cancer (
reprinted from "China News Network")
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
